Govt has identified AMR as key priority in national health policy: Centre

Govt has identified antimicrobial resistance as a key priority in national health policy and a series of initiatives have been taken to build systems to counter it, Union minister Bharti Pawar said

medicine, drugs, antibiotics
Photo: Shutterstock
Press Trust of India New Delhi
2 min read Last Updated : Nov 25 2022 | 10:47 PM IST

The government has identified antimicrobial resistance as a key priority in its national health policy and a series of initiatives have been taken to build systems to counter it, Union minister Bharti Pawar said on Friday.

Pawar was delivering India's national statement at the third Global High-Level Ministerial Conference on AMR at Muscat in Oman.

The minister of State for Health said India's example of prioritizing the development and implementation of state action plans for containment of AMR is a best practice that can be further discussed and emulated by other countries, a Union Health Ministry statement quoting the minister said.

Pawar elaborated that India's National Action Plan for containment of AMR (NAP-AMR) was officially released on April 19, 2017.

The Delhi Declaration on AMR, which is an inter-ministerial consensus, was signed at the launch of NAP-AMR, by the ministers of the concerned ministries pledging their whole-hearted support in AMR containment.

She emphasized that "the National Action Plan for containment of AMR focuses on an integrated 'One Health' approach and involves coordination among various sectors at the state, national and international level".

She said the NAP for containment of AMR serves to leverage the strengths of various institutions such as the National Centre for Disease Control and Indian Council of Medical Research to coordinate AMR surveillance lab networks, monitor antimicrobial consumption in health facilities, strengthen infection prevention and control, as well as promote antimicrobial stewardship to optimize use of antimicrobials.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Antibiotic resistancehealth newsHealth Ministry

First Published: Nov 25 2022 | 10:47 PM IST

Next Story